Russo, E.B. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7), 1344-1364.

Blessing, E.M., et al. (2015). Cannabidiol as a Potential Treatment for Anxiety Disorders. Neurotherapeutics, 12(4), 825-836.

Citti, C., et al. (2019). Δ9-Tetrahydrocannabiphorol: A Novel Phytocannabinoid. Scientific Reports (Nature), 9, 20335.

Booth, J.K. & Bohlmann, J. (2019). Terpenes in Cannabis sativa — From Plant Genome to Humans. Plant Science, 284, 67-72.

Borrelli, F., et al. (2013). Cannabigerol (CBG) and Its Potential Therapeutic Applications. Biochemical Pharmacology, 85(3), 380-388.

Gertsch, J., et al. (2008). Beta-Caryophyllene Is a Dietary Cannabinoid. PNAS, 105(26), 9099-9104.

Harada, H., et al. (2018). Linalool Odor-Induced Anxiolytic Effects in Mice. Frontiers in Behavioral Neuroscience, 12, 241.

Woodhams, S.G., et al. (2017). Cannabinoids and Pain: New Insights from Old Molecules. Frontiers in Pharmacology, 8, 13.

Murillo-Rodriguez, E., et al. (2021). Cannabinol and Sleep: Revisiting the Evidence. Frontiers in Psychiatry, 12, 629797.

d'Alessio, P.A., et al. (2021). Limonene in Cannabis: Anti-Stress and Antidepressant Effects. Cannabis and Cannabinoid Research, 6(4), 327-334.

Salehi, B., et al. (2019). α-Pinene: Memory, Airway, and Acetylcholinesterase Inhibition. Biomolecules, 9(11), 738.

Pertwee, R.G. (2014). Tetrahydrocannabivarin (THCV): A Promising Compound. British Journal of Pharmacology, 171(16), 3859-3870.

Pamplona, F.A., et al. (2018). Whole Plant Cannabis vs. Single-Molecule Approaches. Frontiers in Neurology, 9, 759.

Mouslech, Z. & Valla, V. (2009). Endocannabinoid System: Role in Human Physiology and Pathophysiology. Neuroscience & Medicine, 1, 1-9.

Shinjyo, T. & Di Marzo, V. (2013). Cannabichromene (CBC): Pharmacological Profile and Neurogenesis. Neurochemistry International, 63(5), 422-428.

Crippa, J.A., et al. (2009). Cannabis and Anxiety: A Critical Review. Human Psychopharmacology, 24(6), 515-523.

Geci, M., et al. (2023). D8-THC: Pharmacology and Therapeutic Applications. Molecules, 28(10), 4012.

Legault, J. & Pichette, A. (2007). Humulene as an Anti-tumor Agent. British Journal of Pharmacology, 150(8), 965-974.

Li, Q., et al. (2008). Forest Bathing (Shinrin-yoku) and Immune Function. International Journal of Immunopathology and Pharmacology, 21(2), 323-330.

Prasad, S.N., et al. (2021). Geraniol: Neuroprotective and Therapeutic Properties. Frontiers in Pharmacology, 12, 647928.

Quintans-Júnior, L.J., et al. (2020). Ocimene: Biological Activities and Therapeutic Potential. Molecules, 25(23), 5479.

Ito, Y. & Ito, T. (2013). Terpinolene: Antioxidant and Sedative Effects. Journal of Natural Medicines, 67(3), 648-652.

Rocha, N.F.M., et al. (2011). Bisabolol: Anti-inflammatory, Anti-irritant, and Wound Healing. Pharmacological Research, 64(5), 494-499.

Guindon, J. & Hohmann, A.G. (2009). The Endocannabinoid System and Pain. British Journal of Pharmacology, 156(6), 957-970.

Fiz, J., et al. (2011). Cannabis Use in Patients with Fibromyalgia. PLOS ONE, 6(4), e18440.

Passie, T., et al. (2012). Cannabinoids in the Management of PTSD. Drug Testing and Analysis, 4(7-8), 547-552.

Linge, R., et al. (2016). CBD and Neuroplasticity: Implications for Depression. Neuropharmacology, 103, 165-174.

Collin, C., et al. (2010). Cannabis and Multiple Sclerosis Spasticity. European Journal of Neurology, 17(6), 815-821.

Guzmán, M. (2003). Anti-tumor Activity of Cannabinoids. Nature Reviews Cancer, 3(10), 739-745.

Devinsky, O., et al. (2017). Cannabidiol as an Anti-Seizure Medication. New England Journal of Medicine, 376(21), 2011-2020.

Farha, M.A., et al. (2020). Cannabigerol (CBG) as an Antibacterial Agent. mBio, 11(2), e00507-20.

Whiting, P.F., et al. (2015). Cannabis for Chemotherapy-Induced Nausea: Systematic Review. JAMA, 313(24), 2456-2471.

Englund, A., et al. (2013). Cannabidiol (CBD) Attenuates THC-Induced Psychotic-Like Symptoms. Pharmacology Biochemistry and Behavior, 109, 124-131.

Morgan, C.J., et al. (2010). Sub-Chronic CBD Treatment Attenuates THC Cognitive and Psychotomimetic Effects. Neuropsychopharmacology, 35(8), 1876-1886.

Tashkin, D.P. (2013). Cannabis Smoking and Lung Function: A Systematic Review. Annals of the American Thoracic Society, 10(4), 366-371.

Naftali, T., et al. (2013). Cannabis Induces Clinical Remission in Crohn's Disease. Clinical Gastroenterology and Hepatology, 11(10), 1276-1280.

Wilsey, B., et al. (2013). Low-Dose Vaporized Cannabis for Neuropathic Pain. Journal of Pain, 14(2), 136-148.

Ellis, R.J., et al. (2009). Smoked Cannabis for HIV-Associated Sensory Neuropathy. Neuropsychopharmacology, 34(3), 672-680.

Bergamaschi, M.M., et al. (2011). Cannabidiol Safety and Tolerability: A Review. Current Pharmaceutical Design, 17(10), 963-989.

Rosenberg, E.C., et al. (2015). Cannabinoids in the Treatment of Dementia-Related Agitation. American Journal of Hospice & Palliative Medicine, 32(5), 548-554.

Aggarwal, S.K., et al. (2009). Medicinal Use of Cannabis for Chronic Non-Cancer Pain. Pain Medicine, 10(8), 1442-1452.

ElSohly, M.A., et al. (2016). Cannabis Potency Monitoring: THC Trends Over Two Decades. Biological Psychiatry, 79(7), 612-619.

Bhattacharyya, S., et al. (2012). Neural Mechanisms of THC-Induced Psychotic Symptoms. Archives of General Psychiatry, 69(7), 695-704.

Millar, S.A., et al. (2019). CBD Pharmacokinetics and Drug–Drug Interactions. Epilepsia, 60(3), 474-481.